Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis

被引:82
作者
Mily, Akhirunnesa [1 ]
Rekha, Rokeya Sultana [1 ,2 ]
Kamal, S. M. Mostafa [3 ]
Akhtar, Evana [1 ]
Sarker, Protim [1 ,2 ]
Rahim, Zeaur [1 ]
Gudmundsson, Gudmundur H. [4 ]
Agerberth, Birgitta [2 ]
Raqib, Rubhana [1 ]
机构
[1] Bangladesh Icddr B, Int Ctr Diarrheal Dis Res, Dhaka 1212, Bangladesh
[2] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden
[3] Natl Inst Dis Chest & Hosp, Dhaka 1212, Bangladesh
[4] Univ Iceland, Inst Biol, IS-101 Reykjavik, Iceland
基金
瑞典研究理事会;
关键词
Innate immunity; Antimicrobial peptides; Monocyte derived macrophages; Mycobacterium; MYCOBACTERIUM-TUBERCULOSIS; ANTIMICROBIAL PEPTIDES; SODIUM-BUTYRATE; DOUBLE-BLIND; EXPRESSION; INDUCTION; AUTOPHAGY; DEFENSINS; DNA;
D O I
10.1186/1471-2466-13-23
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: We earlier showed that 4-phenylbutyrate (PB) can induce cathelicidin LL-37 expression synergistically with 1,25-dihydroxyvitamin D-3 in a lung epithelial cell line. We aimed to evaluate a therapeutic dose of PB alone or in combination with vitamin D-3 for induction of LL-37 expression in immune cells and enhancement of antimycobacterial activity in monocyte-derived macrophages (MDM). Methods: Healthy volunteers were enrolled in an 8-days open trial with three doses of PB [250 mg (Group-I), 500 mg (Group-II) or 1000 mg (Group-III)] twice daily (b.d.) together with vitamin D-3 {5000 IU once daily (o.d.)}, PB (500 mg b.d.) (Group-IV) or vitamin D-3 (5000 IU o.d.) (Group-V), given orally for 4 days. Blood was collected on day-0, day-4 and day-8; plasma was separated, peripheral blood mononuclear cells (PBMC), non-adherent lymphocytes (NAL) and MDM were cultured. LL-37 transcript in cells and peptide concentrations in supernatant were determined by qPCR and ELISA, respectively. In plasma, 25-hydorxyvitamin D-3 levels were determined by ELISA. MDM-mediated killing of Mycobacterium tuberculosis (Mtb) (H37Rv) was performed by conventional culture method. Results: MDM from Group-II had increased concentration of LL-37 peptide and transcript at day-4, while Group-I showed increased transcript at day-4 and day-8 compared to day-0 (p < 0.05). Both Group-I and -II exhibited higher levels of transcript on day-4 compared to Group-III and Group-V (p < 0.035). Increased induction of peptide was observed in lymphocytes from Group-II on day-4 compared to Group-I and Group-IV (p < 0.05), while Group-IV showed increased levels on day-8 compared to Group-I and Group-III (p < 0.04). Intracellular killing of Mtb on day-4 was significantly increased compared to day-0 in Group-I, -II and -V (p < 0.05). Conclusion: The results demonstrate that 500 mg b.d. PB with 5000 IU o.d. vitamin D-3 is the optimal dose for the induction of LL-37 in macrophages and lymphocytes and intracellular killing of Mtb by macrophages. Hence, this dose has potential application in the treatment of TB and is now being used in a clinical trial of adults with active pulmonary TB (NCT01580007).
引用
收藏
页数:8
相关论文
共 32 条
[1]   The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations [J].
Agerberth, B ;
Charo, J ;
Werr, J ;
Olsson, B ;
Idali, F ;
Lindbom, L ;
Kiessling, R ;
Jörnvall, H ;
Wigzell, H ;
Gudmundsson, GH .
BLOOD, 2000, 96 (09) :3086-3093
[2]   Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37 [J].
Bergman, P ;
Johansson, L ;
Asp, V ;
Plant, L ;
Gudmundsson, GH ;
Jonsson, AB ;
Agerberth, B .
CELLULAR MICROBIOLOGY, 2005, 7 (07) :1009-1017
[3]   Multiple drug-resistant tuberculosis [J].
Bradford, WZ ;
Daley, CL .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1998, 12 (01) :157-+
[4]   Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1 [J].
Campbell, Grant R. ;
Spector, Stephen A. .
AUTOPHAGY, 2012, 8 (10) :1523-1525
[5]  
DEHAAN JB, 1986, CANCER RES, V46, P713
[6]   T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism [J].
Edfeldt, Kristina ;
Liu, Philip T. ;
Chun, Rene ;
Fabri, Mario ;
Schenk, Mirjam ;
Wheelwright, Matthew ;
Keegan, Caroline ;
Krutzik, Stephan R. ;
Adams, John S. ;
Hewison, Martin ;
Modlin, Robert L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (52) :22593-22598
[7]   HIV Coinfection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality [J].
Gandhi, Neel R. ;
Shah, N. Sarita ;
Andrews, Jason R. ;
Vella, Venanzio ;
Moll, Anthony P. ;
Scott, Michelle ;
Weissman, Darren ;
Marra, Claudio ;
Lalloo, Umesh G. ;
Friedland, Gerald H. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (01) :80-86
[8]   Defensins: Antimicrobial peptides of innate immunity [J].
Ganz, T .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (09) :710-720
[9]   Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator [J].
Islam, D ;
Bandholtz, L ;
Nilsson, J ;
Wigzell, H ;
Christensson, B ;
Agerberth, B ;
Gudmundsson, GH .
NATURE MEDICINE, 2001, 7 (02) :180-185
[10]   The role of the multifunctional peptide LL-37 in host defense [J].
Kai-Larsen, Ylva ;
Agerberth, Birgitta .
FRONTIERS IN BIOSCIENCE, 2008, 13 :3760-3767